Detalles de la búsqueda
1.
Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab.
N Engl J Med;
376(16): 1517-1526, 2017 04 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-28304227
2.
Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.
N Engl J Med;
376(16): 1527-1539, 2017 04 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-28304242
3.
Evaluating bococizumab, a monoclonal antibody to PCSK9, on lipid levels and clinical events in broad patient groups with and without prior cardiovascular events: Rationale and design of the Studies of PCSK9 Inhibition and the Reduction of vascular Events (SPIRE) Lipid Lowering and SPIRE Cardiovascular Outcomes Trials.
Am Heart J;
178: 135-44, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27502861
4.
Intersession variability in single-breath diffusing capacity in diabetics without overt lung disease.
Am J Respir Crit Care Med;
178(3): 225-32, 2008 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18467511
5.
Assessing the Potential Risk of Cross-Reactivity Between Anti-Bococizumab Antibodies and Other Anti-PCSK9 Monoclonal Antibodies.
BioDrugs;
33(5): 571-579, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31529318
6.
Standardization of the single-breath diffusing capacity in a multicenter clinical trial.
Chest;
132(4): 1191-7, 2007 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17890472
7.
Ponezumab in mild-to-moderate Alzheimer's disease: Randomized phase II PET-PIB study.
Alzheimers Dement (N Y);
3(3): 393-401, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29067345
8.
Multiple-dose ponezumab for mild-to-moderate Alzheimer's disease: Safety and efficacy.
Alzheimers Dement (N Y);
3(3): 339-347, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29067341
9.
Trough insulin levels in bronchoalveolar lavage following inhaled human insulin (Exubera) in patients with diabetes mellitus.
Diabetes Technol Ther;
14(1): 50-8, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21875362
10.
Assessment of long-term immunological and pulmonary safety of inhaled human insulin with up to 24 months of continuous therapy.
Curr Med Res Opin;
24(11): 3073-83, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18828959
Resultados
1 -
10
de 10
1
Próxima >
>>